cust.co / Compare / Doximity vs Guardant Health

Doximity vs Guardant Health - NRR head-to-head

Side-by-side Net Revenue Retention comparison sourced from SEC filings and earnings releases. Both compete in Healthcare SaaS. Both at Public stage.

Guardant Health leads by +8pp on latest NRR (117% vs 109%).

NRR over time

99%120%141%162%183% FY2021-Q2FY2022-Q1FY2022-Q4FY2024-Q1FY2025-Q2FY-2025FY2026-Q3FY-2023FY2023-Q4 NRR Doximity Guardant Health Doximity - FY2021-Q2: 167% Doximity - FY2021-Q3: 173% Doximity - FY-2021: 117% Doximity - FY2022-Q1: 139% Doximity - FY2022-Q2: 139% Doximity - FY2022-Q3: 128% Doximity - FY2022-Q4: 133% Doximity - FY-2022: 119% Doximity - FY2023-Q1: 153% Doximity - FY2024-Q1: 117% Doximity - FY2024-Q2: 114% Doximity - FY2025-Q1: 114% Doximity - FY2025-Q2: 119% Doximity - FY2025-Q3: 117% Doximity - FY2025-Q4: 119% Doximity - FY-2025: 119% Doximity - FY2026-Q1: 118% Doximity - FY2026-Q2: 118% Doximity - FY2026-Q3: 112% Doximity - FY2026-Q4: 109% Doximity - FY-2026: 109% Guardant Health - FY-2023: 117% Guardant Health - FY2023-Q4: 117%

Doximity hit a higher all-time peak (173% in FY2021-Q3).

Stat-by-stat

Metric Doximity Guardant Health
Latest NRR 109% 117%
All-time peak NRR 173% 117%
All-time low NRR 109% 117%
QoQ change +0pp +0pp
YoY change -9pp -
3-year change -58pp -
Disclosures tracked 21 2

Customer cohorts

MetricDoximityGuardant Health
Total customers - 200
Over $100K ARR 126 350
Over $1M ARR - 42
Top-10 concentration - 12%
Average ACV - -
US revenue mix 100% 95.2%

Commercial structure

MetricDoximityGuardant Health
Total RPO - $850M
Current RPO (12mo) - $520M
Multi-year contracts - 42%
Avg contract length - 24 mo
Subscription rev mix 94% 88%
New customers added 17 450

Post-sales motion

MetricDoximityGuardant Health
CS team size - -
Customers per CSM - -
Pricing model subscription hybrid
Renewal cadence annual consumption
CSM coverage model account-named account-named
Top customer exec Lisa Greenbaum -

How does your NRR stack up?

Compute yours in 30 seconds. Get a live retention report showing where you stack up, your expansion gap, and which public companies sit closest to your numbers.